Multimorbidity and Subjective Cognitive Complaints: Findings from 48 Low- and Middle-Income Countries of the World Health Survey 2002-2004.


Por: Koyanagi A, Smith L, Shin JI, Hans Oh, Kostev K, Jacob L., Abduljabbar AS and Haro JM

Publicada: 1 ene 2021 Ahead of Print: 10 may 2021
Resumen:
BACKGROUND: Data on the association between multimorbidity and subjective cognitive complaints (SCC) are lacking from low- and middle-income countries (LMICs). OBJECTIVE: To assess the association between multimorbidity and SCC among adults from 48 LMICs. METHODS: Cross-sectional, community-based data were analyzed from the World Health Survey 2002-2004. Ten chronic conditions (angina, arthritis, asthma, chronic back pain, depression, diabetes, edentulism, hearing problems, tuberculosis, visual impairment) were assessed. Two questions on subjective memory and learning complaints in the past 30 days were used to create a SCC scale ranging from 0 (No SCC) to 100 (worse SCC). Multivariable linear regression and mediation analyses were conducted to explore the associations. RESULTS: A total of 224,842 individuals aged=18 years [mean (SD) age 38.3 (16.0) years; 49.3% males] constituted the final sample. Compared to no chronic conditions, the mean SCC score was higher by 7.13 (95% CI = 6.57-7.69), 14.84 (95% CI = 13.91-15.77), 21.10 (95% CI = 19.49-22.70), 27.48 (95% CI = 25.20-29.76), and 33.99 (95% CI = 31.45-36.53) points for 1, 2, 3, 4, and=5 chronic conditions. Estimates by sex and age groups (18-44, 45-64,=65 years) were similar. Nearly 30% of the association between multimorbidity (i.e.,=2 chronic conditions) and SCC was explained by psychological factors (i.e., perceived stress, sleep problems, anxiety symptoms). CONCLUSION: Multimorbidity is associated with SCC among adults in LMICs. Future studies should investigate whether addressing psychological factors in people with multimorbidity can improve cognitive function, and whether screening for SCC in individuals with multimorbidity can be a useful tool to identify individuals at particularly high risk for future cognitive decline.

Filiaciones:
Koyanagi A:
 Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, Barcelona, Spain

 ICREA, Barcelona, Spain

Smith L:
 The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK

Shin JI:
 Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea

Hans Oh:
 Suzanne Dworak Peck School of Social Work, University of Southern California, Los Angeles, CA, USA

Kostev K:
 Philipps University of Marburg, Marburg, Germany

Jacob L.:
 Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, Barcelona, Spain

 Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France

Abduljabbar AS:
 King Saud University, Riyadh, Saudi Arabia

Haro JM:
 Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, Barcelona, Spain

 King Saud University, Riyadh, Saudi Arabia
ISSN: 13872877





JOURNAL OF ALZHEIMERS DISEASE
Editorial
SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND, Países Bajos
Tipo de documento: Article
Volumen: 81 Número: 4
Páginas: 1737-1747
WOS Id: 000663926600032
ID de PubMed: 33998540
imagen Green Accepted

MÉTRICAS